Improving Transcriptional Termination of Self-inactivating Gamma-retroviral and Lentiviral Vectors
Open Access
- 1 June 2007
- journal article
- Published by Elsevier BV in Molecular Therapy
- Vol. 15 (6), 1167-1173
- https://doi.org/10.1038/sj.mt.6300152
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Retroviral vector insertion sites associated with dominant hematopoietic clones mark “stemness” pathwaysBlood, 2006
- 3′ End Processing of the Prothrombin mRNA in ThrombophiliaActa Haematologica, 2006
- Equal potency of gammaretroviral and lentiviral SIN vectors for expression of O6-methylguanine–DNA methyltransferase in hematopoietic cellsMolecular Therapy, 2006
- Retroviral insertional mutagenesis: past, present and futureOncogene, 2005
- Polyadenylation: A tail of two complexesCurrent Biology, 2002
- RNA 3′ Readthrough of Oncoretrovirus and Lentivirus: Implications for Vector Safety and EfficacyJournal of Virology, 2002
- The Retroviruses Human Immunodeficiency Virus Type 1 and Moloney Murine Leukemia Virus Adopt Radically Different Strategies To Regulate Promoter-Proximal PolyadenylationJournal of Virology, 2001
- Mechanism and regulation of mRNA polyadenylationGenes & Development, 1997
- Activation of HIV-1 pre-mRNA 3′ processing in vitro requires both an upstream element and TAR.The EMBO Journal, 1992
- Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells.Proceedings of the National Academy of Sciences of the United States of America, 1986